Anda di halaman 1dari 2

DAFTAR PUSTAKA

1. Sun H, Zou, Xinying, Liu L. Epidemiological Factors of Stroke: A Survey of

The Current Status in China. Journal of Stroke. 2013. 15(2): 109-114.


2. Pandian DJ, Sudhan P. Stroke Epidemiology and Stroke Care Services in

India. J Stroke. 2013. 15(3): 128-34.


3. Kesehatan, Departemen; RI, Kementerian Kesehatan. Riset Kesehatan Dasar.

Jakarta: Badan Penelitian dan Pengembangan Kesehatan Departemen

Kesehatan Republik Indonesia. 2013.


4. Guo, Yiwang, et al. Pathophysiology and Biomarkers in Acute Ischemic

StrokeA Review. Tropical Journal of Pharmaceutical Research. 2013. 12(6):

1097-1105.
5. Koda-Kimble, M.A., Young, L.Y., Alldredge, B.K., Corelli, R.L., Guglielmo,

B.J., Kradjan, W.A., Williams, B.R. Applied Therapeutics: The Clinical Use

Of Drugs. 9th Edition. Lippincott Williams & Wilkins, USA. 2009.


6. Yuniadi Y. Intervensi pada Stroke Non-Hemoragik. Jurnal Kardiologi

Indonesia. 2011. 31(3): 153-155.


7. Setyopranoto I. Stroke: Gejala dan Penatalaksanaan. Kalbemed: CDK

185/Vol.38no.4. 2011. p 247-50


8. Saenger, Amy K, Christenson, Robert H. Stroke biomarkers: progress and

challenges for diagnosis, prognosis, differentiation, and treatment. Clinical

chemistry. 2010. 56(1): 21-33.


9. Woodruff, Trent M., et al. Pathophysiology, treatment, and animal and

cellular models of human ischemic stroke. Molecular neurodegeneration.

2011. 6(1): 1.
10. Saenger, Amy K, Christenson, Robert H. Stroke biomarkers: progress and

challenges for diagnosis, prognosis, differentiation, and treatment. Clinical

chemistry. 2010. 56(1): 21-33.


11. Deb, Prabal, Sharma, Suash; Hassan, KM. Pathophysiologic mechanisms of

acute ischemic stroke: an overview with emphasis on therapeutic significance

beyond thrombolysis. Pathophysiology. 2010. 17(3): 197-218.


12. Broughton BRS, Reutens, David C,Sobey, Christopher G. Apoptotic

mechanisms after cerebral ischemia. Stroke. 2009. 40(5): e331-e339.


13. Bivard A, Lin L, Parsonsb, MW. Review of stroke thrombolytics. Journal of

stroke. 2013. 15(2): 90-98.


14. Dimitrios T, RGN. Management of Acute Stroke: A Debate Paper on Clinical

Priorities. A Literature Review. International Journal. 2015. 8(1): 201.


15. Pranata H. Cardiovascular Disease. Scientific Journal of Pharmaceutical

Development and Medical Aplication. Vol. 24, No.2. 2011. p 3-5


16. Goldstein, Larry B. Modern medical management of acute ischemic stroke.

Methodist DeBakey cardiovascular journal. 2014. 10(2): 99.


17. Rother J, Ford GA, Thijs, Vincent NS. Thrombolytics in acute ischaemic

stroke: historical perspective and future opportunities. Cerebrovascular

Diseases. 2013. 35(4): 313-319.


18. El SMJ, EL Zahran, Tharwat, Tamim H. Acute stroke care and thrombolytic

therapy use in a tertiary care center in Lebanon. Emergency medicine

international. 2014.
19. Wardlaw, Joanna M., et al. Recombinant tissue plasminogen activator for

acute ischaemic stroke: an updated systematic review and meta-analysis. The

Lancet. 2012. 379(9834): 2364-72.